Medicalsystem Biotechnology Co., Ltd

300439

CNE100001Z25

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
10.38 ^CNY	+0.97%		-3.17%	-10.59%

Apr. 23	Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medicalsystem Biotechnology Co., Ltd. Approves Final Dividend for 2022

April 26, 2023 at 03:53 pm EDT

Medicalsystem Biotechnology Co., Ltd. approved final Cash dividend/10 shares (tax included) of CNY1.05000000 for 2022.

Latest news about Medicalsystem Biotechnology Co., Ltd

Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18	CI
MedicalSystem Biotechnology Gets Nod to Market Fibrinogen Detection Kit	Mar. 22	MT
Medicalsystem Biotechnology Co., Ltd Announces Board Appointments	Dec. 18	CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
MedicalSystem Biotechnology Registers Thyroid Protein Detection Kit	23-09-04	MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Ningbo Ruiheyuan Biotechnology Co., Ltd. announced that it expects to receive CNY 192 million in funding from Medicalsystem Biotechnology Co., Ltd	23-08-17	CI
MedicalSystem Biotechnology Registers Two New Medical Devices	23-05-22	MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Chen Chaohong completed the acquisition of a 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde.	23-03-01	CI
MedicalSystem Biotechnology Registers Two New Medical Devices in China	23-02-16	MT
MedicalSystem Biotechnology Registers Two New Medical Devices	23-01-31	MT
Chen Chaohong signed the Share Transfer Agreement to acquire 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde for approximately CNY 180 million	22-12-23	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI
Chinese firms expect limited impact from Ukraine crisis; some seek to benefit	22-02-24	RE
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Xiao Yuanfei signed a share transfer agreement to acquire additional 30% stake in Shanghai Rihe Trade Co., Ltd. from Medicalsystem Biotechnology Co.,Ltd for CNY 20 million.	21-08-27	CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Liu Jianfeng agreed to acquire 23% stake in Hunan Pinxin Bioengineering Co., Ltd. from Medicalsystem Biotechnology Co.,Ltd for CNY 22.4 million.	21-08-13	CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-04-26	CI

Chart Medicalsystem Biotechnology Co., Ltd

Duration

Period

Chart Medicalsystem Biotechnology Co., Ltd

More charts

MedicalSystem Biotechnology Co., Ltd. is a China-based company engaged in the research and development, manufacture and distribution of in-vitro diagnostic products. The Companyâs in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The Company mainly operates businesses in domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-24 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD	-10.59%	552M
BIOMÉRIEUX	-4.52%	12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.19%	8.07B
DIASORIN S.P.A.	+8.32%	5.91B
LANTHEUS HOLDINGS, INC.	+28.50%	5.52B
AUTOBIO DIAGNOSTICS CO., LTD.	-8.09%	4.21B
ANDON HEALTH CO., LTD.	+13.49%	2.73B
VITROLIFE AB	-2.93%	2.43B
MYRIAD GENETICS, INC.	+32.24%	2.29B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-3.55%	1.89B

Diagnostic & Testing Substances